Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters

Synapse

Volumn 23, Issue 2, 1996, Pages 61-69

  Scheffel, Ursula ^a   Steinert, Christine ^a   Kim, Sang Eun ^a   Ehlers, Michael D ^a   Boja, John W ^b   Kuhar, Michael J ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NIDA Addiction Research Center   (United States)

Author keywords

Methyl DL p tyrosine; butyrolactone; 3H WIN 35,428; Apomorphine; Bromocriptine; d Amphetamine; DA transporter; Haloperidol; In vivo binding; L Deprenyl; L DOPA

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; APOMORPHINE; BROMOCRIPTINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GAMMA BUTYROLACTONE; HALOPERIDOL; LEVODOPA; METIROSINE; SELEGILINE;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG SCREENING; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AMPHETAMINE; ANIMALS; CARRIER PROTEINS; CEREBELLUM; COCAINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; LEVODOPA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED STRAINS; NERVE TISSUE PROTEINS;

EID: 0029929280     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199606)23:2<61::AID-SYN1>3.0.CO;2-E     Document Type: Article

References (72)

1. Amejdki-Chab, N., Costentin, J., and Bonnett, J.-J. (1992) Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783. J. Neurochem., 58:793-800.
2. 11C-nomifensine and positron emission tomography. Acta Neurol. Scand., 76:283-287.
3. Arai, Y., Kim, S.K., Kinemuchi, H., Tadano, T., Satoh, S.E., Satoh, N., and Kisara, K. (1990) Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine. J. Neurochem., 55:403-408.
4. Axelrod, J. (1954) Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine. J. Pharmacol. Exp. Ther., 110:315-326.
5. Boja, J.W., Carroll, F.I., Rahman, M.A., Abraham, P., Lewin, A.H., and Kuhar, M. J. (1990) New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. Eur. J. Pharmacol., 184:329-332.
6. Boja, J.W., Cline, E.J., Carroll, F.I., Lewin, A.H., Philip, A., Dannals, R., Wong, D., Scheffel, U., and Kuhar, M.J. (1992) High potency cocaine analogs: Neurochemical, imaging and behavioral studies. In: The Neurobiology of Drug and Alcohol Addiction. Ann. N. Y. Acad. Sci., 654:282-291.
7. Brannan, T., Knott, P., Kaufman, H., Leung, L., and Yahr, M. (1989) Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-DOPA. J. Neural Transm., 75:149-157.
8. Brannan, T., Martinez-Tica, J., DiRocco, A., and Yahr, M.D. (1993) Low and high dose bromocriptine have different effects on striatal dopamine release: An in vivo study. J Neural Transm. Park. Dis. Dement. Sect. 6:81-87.
9. Broderick, P.A. (1991) In vivo voltammetric studies on release mechanisms for cocaine with γ-butyrolactone. Pharmacol. Biochem. Behav. 40:969-975.
10. Brown, E.E., Damsma, G., Cumming, P., and Fibiger, H.C. (1991) Interstitial 3-methoxytyramine reflects striatal dopamine release: An in vivo microdialysis study. J. Neurochem., 57:701-707.
11. Buu, N.T. (1989) Vesicular accumulation of dopamine following L-DOPA administration. Biochem. Pharmacol., 38:1787-1792.
12. 3H]WIN 35,428) in the monkey brain. Synapse, 6:189-195.
13. Carroll, F.I., Abraham, P., Lewin, A.H., Parham, K.A., Boja, J.W., and Kuhar, M.J. (1992) Isopropyl and phenyl esters of 3β-(4-substituted phenyl) tropan-2β-carboxylic acids. Potent and selective compounds for the dopamine transporter. J. Med. Chem., 35:2497-2500.
14. Carroll, F.I., Scheffel, U., Dannals, R.F., Boja, J.W., and Kuhar, M.J. (1995) Development of imaging agents for the dopamine transporter. Med. Res. Rev., 15:419-444.
15. Chrapusta, S.J., Karoum, F., Egan, M.F., and Wyatt, R.J. (1992) γ-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions. Eur. J Pharmacol., 222:29-135.
16. 15F]GBR 13119 binding autoradiography in rat brain. J. Neurochem., 55:619-623.
17. 125I]RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse, 12:37-46.
18. Danielson, T.J., and Boulton, A.A. (1976) Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate. Eur. J. Pharmacol., 37:257-264.
19. 11C]WIN-35,428). J. Labelled Compounds and Radiopharmaceuticals, 33:147-152.
20. 18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse, 7:324-327.
21. 11C]DL-threo-methylphenidate: Drug pharmaeokinetics and binding to the presynaptic dopaminergic neuron. Tenth International Symposium on Radiopharmaceutical Chemistry, Kyoto, Japan.
22. Doteuchi, M., Wang, C., and Costa, E. (1974) Compartmentation of dopamine in rat striatum. Mol. Pharmacol., 10:225-234.
23. Ellison, G., Eison, M.S., Huberman, H.S., and Daniel, F. (1978) Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science, 201:276-278.
24. Fowler, J.S., Volkow, N.D., Wolf, A.P., Dewey, S.L., Schlyer, D.J., MacGregor, R.R., Hitzemann, R., Logan, J., Bendriem, B., Gatley, S.J., and Christman, D. (1989) Mapping cocaine binding sites in human and baboon brain in vivo. Synapse, 4:371-377.
25. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol., 34:423-431.
26. 11C-CFT and PET in a primate model of Parkinsonism. NeuroReport, 3:265-268.
27. 3H]-catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues. Neuropharmacology, 12:669-679.
28. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, E.G., Luthra, S.K., Brooks, D.J., and Lammertsma. A.A. (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse, 12:47-54.
29. Kaakkola, S., and Wurtman, R.J. (1993) Effects of catechol-O-methyl-transferase inhibitors and L-3,4-dihydrophenylalanine with or without carbidopa on extracellular dopamine in rat striatum. J. Neurcchem., 60:37-144.
30. 125I]RTI-55. Synapse, 12:99-111.
31. 3H]CFT. Synapse, 9:177-187.
32. 18F]GBR 13119 to the brain dopamine uptake system. Life Sci., 42:1347-1353.
33. 18F]GBR 13119, a dopamine uptake inhibitor, in CD-I and C57BL6 mice. Eur. J. Pharmacol., 166:331-334.
34. 16F]GBR13119. Imaging the dopamine uptake system m vivo. Nucl. Med. Biol., 16:569-576.
35. 18F]GBR 13119 binding to the dopamine uptake site. Eur. J. Pharmacol., 216:109-112.
36. 18F]GBR 12909, a dopamine uptake inhibitor. J. Nuel. Med., 31:720.
37. Koshimura, K, Ohue, T, Akiyama, Y., Itoh, A., and Miwa, S. (1992) L-DOPA administration enhances exocytotic dopamine release in vivo in the rat striatum. Life Sci., 51:747-755.
38. Kurata, K., and Shibata, R. (1991) Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis. Neurosci. Lett., 133:77-80.
39. Lane, J.D., Smith, J.E., Shea. P.A., and McBride, W.J. (1976) Neurochemical changes following the administration of depleters of biogenic monoamines. Life Sci., 19:1663-1668.
40. 18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons. Synapse, 9:95-207.
41. Madras, B.K., Spealman, R.D., Fahey, M.A., Neumeyer, J.L., Saha, J.K., and Milius, R.A. (1989a) Cocaine receptors labeled by PH]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol. Phannacol., 36.518-524.
42. 3H]Cocaine binding sites in caudate putamen. J. Pharmacol. Exp. Ther., 251:150-155.
43. 3H]LU 19-005: Markers for cocaine receptors/dopamine nerve terminals in Parkinson's disease. Soc. Neurosci. Abstr., 16:14.
44. Meltzer, P.C., Liang, A.Y., Brownell, A.L., Elmaleh, D.E., and Madras, B K (1993) Substituted 3-phenyltropane analog of cocaine: Synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J. Med. Chem., 36:855-862.
45. Mizoguchi, K., Yokoo, H., Yoshida, M., Tanaka, T., and Tanaka, M. (1993) Dopamine formation from L-DOPA administered exogenously is independent of dopaminergic neuronal activity: Studies with in vivo microdialysis. Brain Res. 611:152-154.
46. Moghaddam, B., and Bunney, B.S. (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J. Neurochem., 54:1755-1760.
47. Moghaddam, B., Roth, R.H., and Bunney, B.S. (1990) Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: Comparison to the striatum. Neuroscience, 36:669-676.
48. 11C]β-CIT, a cocaine analogue preparation: Autoradiography and preliminary PET investigations. Nucl. Med. Biol., 20:249-255.
49. 123I]-2β-Carbomethoxy-3β-(4-iodophenyl)tropane: high affinity SPECT radiotracer of monoamine reuptake sites in brain. J. Med. Chem., 34:3144-3146.
50. Nissbrandt, H., Sundstrom, E., Jonsson, G., Hjorth, S., and Carlson, A. (1989) Synthesis and release of dopamine in rat brain: Comparison between substantia nigra pars compact, pars reticulata and striatum. J. Neurochem., 52:1170-1182.
51. 3H-WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. Eur. J. Pharmacol., 198:203-205.
52. Porter, C.C., Totaro, J.A., Burcin, A., and Wynosky, E.R. (1965) The effect of the optical isomers of a-methyl-p-tyrosine upon brain and heart catecholamines in the mouse. Biochem. Pharmacol., 15:583-590.
53. Reiriz, J., Ambrosio, S., Cobos, A., Ballarin, M., Tolosa, E., and Mahy, N. (1994) Dopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdyalysis study. J. Neural Transm. Gen. Sect., 95:195-207.
54. Ricaurte, G.A., Seiden, L.S., and Schuster, C.R. (1984) Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res., 303:359-364.
55. Ross, S.B. (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J. Neurochem., 56:22-29.
56. 3H-(-)-N-n-propylnoramorphine in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 340:13-20.
57. Santiago, M., and Westerink, B.H.C. (1991) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J. Neurochem., 57:738-747.
58. Scheffel, U., and Ricaurte, G-A. (1990) Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: A presynaptic serotonergic positron emission tomography ligand? Brain Res., 527:89-95.
59. 3H-WIN 35,428. Synapse, 4:390-392.
60. Scheffel, U., Steinert, C.L., Kuhar, M.J., and Neumeyer, J.L. (1991a) Effect of endogenous dopamine on 3H WIN 35,428 binding to dopamine uptake sites. J. Nucl. Med., 32:1069 (Abstract).
61. 3HJWIN 35,428, J. Pharmacol. Exp. Ther., 257:954-958.
62. Scheffel, U., Dannals, R.F., Wong, D.F., Yokoi, F., Carroll, F.I., and Kuhar, MJ. (1992) Dopamine transporter imaging with novel, selective cocaine analogs. NeuroReport, 3:969-972.
63. Seiden, L.S., and Sabol, K.E. (1993) Amphetamine: Effects on eatecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol., 32:639-677.
64. Ståhle, L., and Ungerstedt, U. (1990) Yawning and suppression of exploration induced by dopamine agonists: No relation to extracellular striatal levels of dopamine. Pharmacol. Biochem. Behav., 35:201-209.
65. Stathis, M., Scheffel, U., Lever, S.Z., Boja, J.W., Carroll, F.I., and Kuhar, M.J. (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology, 119:376-384.
66. 3H]GBR 12783 binding in vivo. Eur. J. Pharmacol., 178:221-227.
67. 11C]Raelopride in the human brain. Synapse, 16:255-262.
68. Wachtel, S.R., and Abercrombie, E.D. (1994) L-3,4-Dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxy-dopamine-treated rats: Differential effects of monoamine oxidase A and B inhibitors. J. Neurochem., 63:108-117.
69. Wagner, G.C., Ricaurte, G.A., Johanson, C.E., Schuster, C.R., and Seiden, L.S. (1980) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30:546-550.
70. Walters, J.R., Aghajanian, G.K, and Roth, R.H. (1972) Dopaminergic neurons: Inhibition of firing by γ-hydroxybutyrate. Proc. Fifth Congr. Pharmacol., p. 246.
71. Wiener, H.L., Hashim, A., Lathja, A., and Sershen, H. (1989) Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier. Eur. J Pharmacol., 163:191-194.
72. 11C]WIN 35,428. Synapse, 15:30-145.